Bo Zhao

Bo Zhao

Auto-generated profile, based on publicly available information

Bo Zhao

Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Science
Verified
Journal Article
Closed access
PDF file
HMHuaixiao Ma
Huaixiao Ma
JZJinglei Zhai
Jinglei Zhai
HWHaifeng Wan
Haifeng Wan
XJXiangxiang Jiang
Xiangxiang Jiang
XWXiaoxiao Wang
Xiaoxiao Wang
HWHongmei Wang
Hongmei Wang
In vitro development of monkey embryos: Owing to technical and ethical limitations, the molecular and cellular mechanisms underlying primate gastrulation are far from clear (see the Perspective by Tam). Two independent studies used an in vitro culture system to study cynomolgus monkey embryo postimplantation development up to and beyond gastrulation (day 9 to day 20). Niu et al. observed in vivo morphogenetic events and used single-cell RNA sequencing and single-cell chromatin accessibility to study the distinct cell lineages in developing embryos. Ma et al. also observed that key events of in vivo early development were recapitulated in their system, and single-cell RNA-sequencing analysis revealed molecular signatures of postimplantation cell types. These systems will help elucidate the dynamics and regulation of gastrulation in primates, including possible relevance to human development. Science , this issue p. eaaw5754 , p. eaax7890 ; see also p. 798

1 December 2017 in Cell Reports
Verified
Journal Article
Open access
SKSergey Karakashev
Sergey Karakashev
HZHengrui Zhu
Hengrui Zhu
YYYuhki Yokoyama
Yuhki Yokoyama
BZBo Zhao
Bo Zhao
NFNail Fatkhutdinov
Nail Fatkhutdinov
RZRugang Zhang
Rugang Zhang
PARP inhibition is known to be an effective clinical strategy in BRCA mutant cancers, but PARP inhibition has not been applied to BRCA-proficient tumors. Here, we show the synergy of BET bromodomain inhibition with PARP inhibition in BRCA-proficient ovarian cancers due to mitotic catastrophe. Treatment of BRCA-proficient ovarian cancer cells with the BET inhibitor JQ1 downregulated the G2-M cell-cycle checkpoint regulator WEE1 and the DNA-damage response factor TOPBP1. Combining PARP inhibitor Olaparib with the BET inhibitor, we observed a synergistic increase in DNA damage and checkpoint defects, which allowed cells to enter mitosis despite the accumulation of DNA damage, ultimately causing mitotic catastrophe. Moreover, JQ1 and Olaparib showed synergistic suppression of growth of BRCA-proficient cancer in vivo in a xenograft ovarian cancer mouse model. Our findings indicate that a combination of BET inhibitor and PARP inhibitor represents a potential therapeutic strategy for BRCA-proficient cancers.

1 February 2020 in Cancer Cell
Verified
Journal Article
Closed access
SKSergey Karakashev
Sergey Karakashev
TFTakeshi Fukumoto
Takeshi Fukumoto
BZBo Zhao
Bo Zhao
JLJianhuang Lin
Jianhuang Lin
SWShuai Wu
Shuai Wu
RZRugang Zhang
Rugang Zhang

19 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BZBo Zhao
Bo Zhao
PLPingyu Liu
Pingyu Liu
TFTakeshi Fukumoto
Takeshi Fukumoto
TNTimothy Nacarelli
Timothy Nacarelli
NFNail Fatkhutdinov
Nail Fatkhutdinov
RZRugang Zhang
Rugang Zhang
Cyclic cGMP-AMP synthase (cGAS) is a pattern recognition cytosolic DNA sensor that is essential for cellular senescence. cGAS promotes inflammatory senescence-associated secretory phenotype (SASP) through recognizing cytoplasmic chromatin during senescence. cGAS-mediated inflammation is essential for the antitumor effects of immune checkpoint blockade. However, the mechanism by which cGAS recognizes cytoplasmic chromatin is unknown. Here we show that topoisomerase 1-DNA covalent cleavage complex (TOP1cc) is both necessary and sufficient for cGAS-mediated cytoplasmic chromatin recognition and SASP during senescence. TOP1cc localizes to cytoplasmic chromatin and TOP1 interacts with cGAS to enhance the binding of cGAS to DNA. Retention of TOP1cc to cytoplasmic chromatin depends on its stabilization by the chromatin architecture protein HMGB2. Functionally, the HMGB2-TOP1cc-cGAS axis determines the response of orthotopically transplanted ex vivo therapy-induced senescent cells to immune checkpoint blockade in vivo. Together, these findings establish a HMGB2-TOP1cc-cGAS axis that enables cytoplasmic chromatin recognition and response to immune checkpoint blockade.

6 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BZBo Zhao
Bo Zhao
JLJianhuang Lin
Jianhuang Lin
LRLijie Rong
Lijie Rong
SWShuai Wu
Shuai Wu
ZDZhong Deng
Zhong Deng
RZRugang Zhang
Rugang Zhang
ARID1A inactivation causes mitotic defects. Paradoxically, cancers with high ARID1A mutation rates typically lack copy number alterations (CNAs). Here, we show that ARID1A inactivation causes defects in telomere cohesion, which selectively eliminates gross chromosome aberrations during mitosis. ARID1A promotes the expression of cohesin subunit STAG1 that is specifically required for telomere cohesion. ARID1A inactivation causes telomere damage that can be rescued by STAG1 expression. Colony formation capability of single cells in G2/M, but not G1 phase, is significantly reduced by ARID1A inactivation. This correlates with an increase in apoptosis and a reduction in tumor growth. Compared with ARID1A wild-type tumors, ARID1A-mutated tumors display significantly less CNAs across multiple cancer types. Together, these results show that ARID1A inactivation is selective against gross chromosome aberrations through causing defects in telomere cohesion, which reconciles the long-standing paradox between the role of ARID1A in maintaining mitotic integrity and the lack of genomic instability in ARID1A-mutated cancers.

14 October 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
WZWeidao Zhang
Weidao Zhang
ZCZhongliang Chen
Zhongliang Chen
DZDengfeng Zhang
Dengfeng Zhang
BZBo Zhao
Bo Zhao
LLLu Liu
Lu Liu
PZPing Zheng
Ping Zheng
Recurrent pregnancy loss (RPL) is an important complication in reproductive health. About 50% of RPL cases are unexplained, and understanding the genetic basis is essential for its diagnosis and prognosis. Herein, we report causal KH domain containing 3 like (KHDC3L) mutations in RPL. KHDC3L is expressed in human epiblast cells and ensures their genome stability and viability. Mechanistically, KHDC3L binds to poly(ADP-ribose) polymerase 1 (PARP1) to stimulate its activity. In response to DNA damage, KHDC3L also localizes to DNA damage sites and facilitates homologous recombination (HR)-mediated DNA repair. KHDC3L dysfunction causes PARP1 inhibition and HR repair deficiency, which is synthetically lethal. Notably, we identified two critical residues, Thr145 and Thr156, whose phosphorylation by Ataxia-telangiectasia mutated (ATM) is essential for KHDC3L’s functions. Importantly, two deletions of KHDC3L (p.E150_V160del and p.E150_V172del) were detected in female RPL patients, both of which harbor a common loss of Thr156 and are impaired in PARP1 activation and HR repair. In summary, our study reveals both KHDC3L as a new RPL risk gene and its critical function in DNA damage repair pathways.